ABBOTT LABORATORIESABT

時価総額

$2229.7億

PER

医療機器・診断・栄養製品の最大手。FreeStyle LibreのCGM、心血管デバイスやペースメーカー、AlinityやBinaxNOW等の診断システム、Similac等の栄養製品を展開。2023年4月にCSIを8.51億ドルで買収、2023年9月にBigfoot買収。世界約160カ国で展開。

概要財務

サマリーテーブルに戻る

	2010年 12月31日	2011年 12月31日	2012年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Cash and cash equivalents	3,648	6,813	10,802	3,475	4,063	5,001	18,620	9,407	3,844	3,860	6,838	9,799	9,882	6,896	7,616
Short-Term Investments	1,803	1,285	4,372	4,623	397	1,124	155	203	242	280	310	450	288	383	351
Accounts Receivable, after Allowance for Credit Loss, Current	7,184	7,684	7,613	3,986	3,586	3,418	3,248	5,249	5,182	5,425	6,414	6,487	6,218	6,565	6,925
Finished products	-	-	-	-	-	-	1,624	2,339	2,407	2,784	3,030	3,081	3,805	3,946	3,700
Work in process	-	-	-	-	-	-	294	472	499	560	712	694	680	807	840
Materials	-	-	-	-	-	-	516	790	890	972	1,270	1,382	1,688	1,817	1,654
Total inventories	3,189	3,284	3,792	2,693	2,643	2,599	2,434	3,601	3,796	4,316	5,012	5,157	6,173	6,570	6,194
Prepaid Expense and Other Receivables	-	-	-	-	-	-	-	-	1,559	1,786	1,867	2,346	2,663	2,256	2,570
Total current assets	22,318	23,769	31,323	19,247	15,261	14,155	26,776	20,147	14,632	15,667	20,441	24,239	25,224	22,670	23,656
Investments	302	378	274	119	229	4,041	2,947	883	897	883	821	816	766	799	886
Land	649	634	604	502	457	432	408	526	501	519	538	525	511	529	528
Buildings	4,334	4,467	4,259	2,994	2,968	2,769	2,602	3,613	3,555	3,702	4,014	4,007	4,053	4,161	4,207
Equipment	11,814	12,216	13,111	8,506	8,480	8,254	8,394	10,394	10,756	11,468	12,884	13,528	14,164	15,179	15,517
Construction in progress	577	699	954	868	727	928	962	732	894	1,110	1,357	1,304	1,484	2,064	2,488
Property and equipment, at cost	17,374	18,017	18,929	12,870	12,632	12,383	12,366	15,265	15,706	16,799	18,793	19,364	20,212	21,933	22,740
Less: accumulated depreciation and amortization	9,403	10,143	10,866	6,965	6,697	6,653	6,661	7,658	8,143	8,761	9,764	10,405	11,050	11,779	12,082
Net property and equipment	7,971	7,874	8,063	5,905	5,935	5,730	5,705	7,607	7,563	8,038	9,029	8,959	9,162	10,154	10,658
Intangible assets, net of amortization	12,152	9,990	8,588	5,735	6,198	5,562	4,539	21,473	18,942	17,025	14,784	12,739	10,454	8,815	6,647
Goodwill	15,930	15,705	15,774	9,772	10,067	9,638	7,683	24,020	23,254	23,200	23,700	23,200	22,800	23,700	23,100
Deferred income taxes and other assets	-	-	-	-	-	-	2,263	1,944	1,868	3,079	3,729	5,212	6,033	7,097	16,459
Total Assets	59,462	60,277	67,235	42,953	41,275	41,247	52,666	76,250	67,173	67,887	72,548	75,196	74,438	73,214	81,414
Trade accounts payable	1,536	1,721	1,797	1,026	1,064	1,081	1,178	2,402	2,975	3,252	3,946	4,408	4,607	4,295	4,195
Salaries, wages and commissions	-	1,260	1,428	906	776	746	752	1,187	1,182	1,237	1,416	1,625	1,556	1,597	1,701
Other accrued liabilities	6,015	7,855	6,788	3,500	2,943	3,043	2,581	3,811	3,780	4,035	5,165	5,181	5,845	5,422	5,143
Dividends payable	-	754	221	341	362	383	391	489	563	635	798	831	887	955	1,024
Income taxes payable	1,308	515	655	175	270	430	188	309	305	226	362	306	343	492	594
Current portion of long-term debt	2,045	1,027	309	9	55	3	3	508	7	1,277	7	754	2,251	1,080	1,500
Total current liabilities	17,262	15,480	13,280	9,507	10,532	9,186	6,660	8,912	9,012	10,863	11,907	13,105	15,489	13,841	14,157
Long-term debt	12,524	12,040	18,085	3,388	3,408	5,871	20,681	27,210	19,359	16,661	18,527	17,296	14,522	13,599	12,625
Post-employment obligations and other long-term liabilities	-	-	-	-	-	-	-	-	8,080	9,062	9,111	8,771	7,522	6,947	6,731
Common Stock, Value, Issued	8,745	-	-	12,048	12,383	12,734	13,027	23,206	23,512	23,853	24,145	24,470	24,709	24,869	25,153
Common shares held in treasury, at cost — Shares: 2024: 259,774,639; 2023: 253,807,494	-	-	-	-	-	-	10,791	10,225	9,962	10,147	10,042	11,822	15,229	15,981	16,844
Earnings employed in the business	18,927	20,907	24,151	21,979	22,874	25,757	25,565	23,978	24,560	25,847	27,627	31,528	35,257	37,554	47,261
Accumulated other comprehensive income (loss)	-1,367	-2,597	-3,594	-2,012	-5,053	-6,658	-7,263	-6,062	-7,586	-8,465	-8,946	-8,374	-8,051	-7,839	-7,906
Total Abbott Shareholders’ Investment	22,476	24,526	26,813	25,267	21,639	21,326	20,717	31,098	30,722	31,301	33,003	36,024	36,905	38,827	47,901
Noncontrolling interests in subsidiaries	88	86	92	96	113	115	179	201	198	213	219	222	219	224	237
Total Shareholders’ Investment	22,476	24,526	26,813	25,267	21,639	21,326	20,717	31,098	30,722	31,301	33,003	36,024	36,905	38,827	47,901
Total Liabilities and Shareholders' Investment	59,462	60,277	67,235	42,953	41,275	41,247	52,666	76,250	67,173	67,887	72,548	75,196	74,438	73,214	81,414